Achieve Life Sciences Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$4.25

+0.30 (+7.59%)

As of Feb 8, 2:04 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +650.4% upside

Low Target $22.93

Average Target $31.89

High Target $41.27

Current Price $4.25

Current
$4.25

Target
$31.89

$22.93 $31.89 avg $41.27

Scenario Analysis

Bear Case

$22.93

439.5%

Low target

Base Case

$31.89

+650.4%

Avg target

Bull Case

$41.27

+871.1%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$31.44

-86.5% from high

52-Week Low

$15.14

+-71.9% from low

Target vs 52W High

$31.89

+1.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%